Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-03-28

FDA Approved: NITHIODOTE — Supplemental Application (Hope Pharmaceuticals)

View source ↗

Summary

FDA approved Hope Pharmaceuticals' supplemental application for NITHIODOTE (sodium nitrite and sodium thiosulfate), expanding its labeling for emergency treatme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NITHIODOTE (Sodium nitrite and sodium thiosulfate)

Snippet

SUPPL AP for NITHIODOTE (SODIUM NITRITE AND SODIUM THIOSULFATE)